did the fda ban tirzepatide will reconsider decision barring copycat versions of Lilly weight loss drug The FDA is proposing a

Thyroid or endocrine disorders: Specifically, those with a personal or family history of Medullary Thyroid Cancer or Multiple Endocrine Neoplasia Syndrome Type 2 (MEN 2)

Leaves, dirt, and other debris on the gutter keep dampness, ideal for mosquitoes to breed

The bigger picture This deal reflects a broader shift in pharma strategy: From blockbuster innovation to scale-driven accessibility From single-company dominance to strategic partnerships From diabetes drugs to holistic metabolic disease management The real question is not whether GLP-1 therapies will reshape healthcare

Table 2 NSCLC, non-small cell lung cancer

For Fierstein, taking a GLP-1 makes him feel different than when he was just dieting